DUBLIN--(BUSINESS WIRE)--Jul 13, 2018--The "Europe Prostate Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Prostate Cancer epidemiology, Prostate Cancer diagnosed patients, and Prostate Cancer treatment rate for EU5 countries. The research measures key indicators including prevalence of Prostate Cancer derived from epidemiological analysis, patients diagnosed with Prostate Cancer, and patients treated with a drug therapy.

The research study helps executives estimate Prostate Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Prostate Cancer prevalence, Prostate Cancer diagnosis rate, and Prostate Cancer treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Topics Covered

1. Prostate Cancer: Disease Definition

2. Prostate Cancer Patient Flow in Europe

2A. Prostate Cancer Prevalence in Europe

2B. Prostate Cancer Diagnosed Patients in Europe

2C. Prostate Cancer Treated Patients in Europe

3. Prostate Cancer Patient Flow in Germany

3A. Prostate Cancer Prevalence in Germany

3B. Prostate Cancer Diagnosed Patients in Germany

3C. Prostate Cancer Treated Patients in Germany

4. Prostate Cancer Patient Flow in France

4A. Prostate Cancer Prevalence in France

4B. Prostate Cancer Diagnosed Patients in France

4C. Prostate Cancer Treated Patients in France

5. Prostate Cancer Patient Flow in Spain

5A. Prostate Cancer Prevalence in Spain

5B. Prostate Cancer Diagnosed Patients in Spain

5C. Prostate Cancer Treated Patients in Spain

6. Prostate Cancer Patient Flow in Italy

6A. Prostate Cancer Prevalence in Italy

6B. Prostate Cancer Diagnosed Patients in Italy

6C. Prostate Cancer Treated Patients in Italy

7. Prostate Cancer Patient Flow in UK

7A. Prostate Cancer Prevalence in UK

7B. Prostate Cancer Diagnosed Patients in UK

7C. Prostate Cancer Treated Patients in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/pzsssb/europe_prostate?w=4

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005182/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Prostate Cancer Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/13/2018 08:07 AM/DISC: 07/13/2018 08:07 AM

http://www.businesswire.com/news/home/20180713005182/en